REFERENCES
- Budavari S. The Merck Index. 12th Ed, Merck & Co, Inc, Whitehouse Station, NJ 1996; 1314
- Elder R. C., Zhao Z., Zhang Y., Dorsey J. G., Hess E. V. Dicyanogold (I) is a Common Human Metabolite of Different Gold Drugs. J. Rheumatol. 1993; 20(2)268–272
- Pontal P. G., Bismuth C., Garnier R., DE Garbino P. J. Therapeutic Attitude to Cyanide Poisoning: Retrospective Study of 24-Nonlethal Cases. Vet. Human. Toxicol. 1982; 24(suppl.)90–94
- Wright I. H., Vesey C. J. Acute Poisoning with Gold Cyanide. Anaesthesia 1986; 41(9)936–939
- Olson K. R. Poisoning and Drug Overdose. 3rd Ed, Appleton & Lange, A Simon & Schuster Company, , Connecticut 1999; 150–152
- Bailar J. C., Emelesus H. J., Nyholm R., Trotman-Dickenson A. F. Comprehensive Inorganic Chemistry. Pergamon Press, Oxford 1973; 3: 139–186
- Drugdex: Gold Drug. Micromedex, Inc. 2001; 108
- Budden M. G., Wilkinson D. S. Skin and Nail Lesions from Gold Potassium Cyanide. Contact Dermatitis 1978; 4(3)172–173
- Wrangsjo K., Martensson A. Hydrazine Contact Dermatitis from Gold Plating. Contact Dermatitis 1986; 15(4)244–245
- Dienstag J. L., Isselbacher K. J. Toxic and Drug Induced Hepatitis. Harrison's Principles of Internal Medicine, K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, D. L. Kasper. McGraw-Hill, Inc., New York 1994; 1474–1475
- Schenker S., Olson K. N., Dunn D., Breen K. J. Intrahepatic Cholestasis Due to Therapy of Rheumatoid Arthritis. Gastroenterology 1973; 64(4)622–699
- Favreau M., Tannenbaum H., Lough J. Hepatic Toxicity Associated with Gold Therapy. Ann. Intern. Med. 1977; 87(6)717–719
- Ghishan F. K., LaBrecque D. R., Younoszai K. Intrahepatic Cholestatis After Gold Therapy in Juvenile Rheumatoid Arthritis. J. Pediatr. 1978; 93(6)1042–1043
- Pessayre D., Feldmann G., Degott C., Ulmann A., Roger W., Erlinger S., Benhamou J. P. Gold Salt-Induced Cholestasis. Digestion 1979; 19(1)56–64
- Edelman J., Donnelly R., Graham D. N., Percy J. S. Liver Dysfunction Associated with Gold Therapy for Rheumatoid Arthritis. J. Rheumatol. 1983; 10(3)510–511
- Hanissian A. S., Rothschild B. M., Kaplan S. Gold: Hepatoxic and Cholestatic Reactions. Clin. Rheum. 1985; 4(2)183–188
- Harats N., Shalit M., Ehrenfeld M., Lijovetzky G. Gold-Induced Granulomatous Hepatitis. Isr. J. Med. Sci. 1985; 21(9)753–756
- Hansen R. M., Varma R. R., Hanson G. A. Gold-Induced Hepatitis and Pure Red Cell Aplasia. Complete Recovery After Corticosteroid and N-Acetylcysteine Therapy. J. Rheumatol. 1991; 18(8)1251–1253
- Clayton G. D., Clayton F. E. Patty's Industrial Hygiene and Toxicology. 4th Ed, John Wiley & Sons, Inc., New York 1996; 2c: 2025
- Dahl S. L., Coleman M. L., Willaims H. J., Altz-Smith M., Kay D. R., Paulus H. E., Weinstein A., Kaplan S. Lack of Correlation Between Blood Gold Concentrations and Clinical Response in Patients with Definite or Classic Rheumatoid Arthritis Receiving Auranofin or Gold Sodium Thiomalate. Arthritis Rheum. 1985; 28(11)1211–1218
- Pedersen S. M., Graabaek P. M. Gold in Erythrocytes, Whole Blood and Plasma During Long-Term Chrysotherapy. Ann. Rheum. Dis. 1980; 39(6)576–579